Latest News & Features
Europe
An Australian personalised genomics company has failed in its effort to obtain protection for its ‘MyDNA.life’ trademark in the UK. 15 October 2020
Biotechnology
A unit belonging to German company Braun has allegedly infringed five patents relating to artificial joints for knee and hip replacements, according to a complaint filed by the Orthopaedic Institute for Children. 13 October 2020
Big Pharma
The Federal Court of Australia has backed Novartis’ appeal against a decision revoking its patent covering a multiple sclerosis drug. 13 October 2020
Big Pharma
Biopharmaceutical company, Moderna, has announced that it will not enforce patents related to its COVID-19 vaccine while the pandemic is ongoing, and that it is prepared to license the patents to others after the pandemic is over. 12 October 2020
Genetics
The Federal Court of Australia has refused to block a cattle genome patent from the US, dismissing an appeal from Meat and Livestock Australia. 12 October 2020
Americas
US Customs and Border Protection officers have seized hundreds of thousands of counterfeit facemasks and unapproved COVID-19 related products worth more than $2.5m during the six weeks leading up to October 1. 8 October 2020
Big Pharma
South Africa and India have asked the World Trade Organization to cede some stipulations governing IP so that treatments to combat COVID-19 can become more widely available, particularly in low-income countries. 8 October 2020
article
As businesses around the world evaluate their options for protecting new technologies, trade secret protection can be an essential complement to patents. In this session, we will evaluate the use of trade secrets protection as an alternative to patenting. 8 October 2020
Americas
French microbiologist Emmanuelle Charpentier and US biochemist Jennifer Doudna have achieved scientific history by jointly winning the Nobel Prize in chemistry for their seminal work on gene-editing technology, CRISPR. 8 October 2020
Biotechnology
Regeneron Pharmaceuticals is facing claims that its “antibody cocktail”, which was administered to President Donald Trump to treat his COVID-19 symptoms, was developed with the unauthorised use of a fluorescent protein. 6 October 2020